Article Details
Retrieved on: 2021-02-23 16:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Previous work has demonstrated efficacy for an IL-1 β monoclonal antibody, canakinumab (Ilaris), and a blinded non-inferiority trial comparing ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here